A space in the anterior region of the dental arch of a youngster, either due to trauma or a congenitally missing tooth, can not only lead to psychological trauma but also create a functional dilemma for the dentist, as the usual treatment options of implant, removable partial denture and fixed partial denture available for adults, are often inapplicable or inconvenient for an adolescent. In such a situation, a resin-bonded fixed partial denture (RBFPD), such as Maryland Bridge fulfills all the requirements of an ideal interim solution till growth completion is achieved and a more permanent tooth replacement option can be explored.
BACKGROUND The vitality of dental pulp is essential for long-term survival of the tooth. Vital pulp therapy (VPT) intends to maintain healthy pulp tissue by eliminating bacteria from the dentin-pulp complex. There are many treatment options for vital pulp therapy in extensively decayed teeth. Pulp capping or pulpotomy procedures rely upon an accurate assessment of the pulp status, and careful management of the remaining pulp tissue. We wanted to evaluate as to whether biodentine total pulpotomy is an effective alternative to conventional endodontic therapy for young permanent teeth. METHODS Full coronal pulpotomy was performed in young permanent molars diagnosed with acute irreversible pulpitis with Biodentine as the pulpotomy medicament. Follow up evaluation was done clinically and radiographically at 3, 6 and 12 months. RESULTS During follow-up periods clinical signs/symptoms were absent including pulpal pain, swelling or presence of sinus and percussion pain. Continuous root development and healing of periapical radiolucency were noticed in the study which were indicative of maintenance of vitality of the pulp. CONCLUSIONS Within the limitations of this clinical study, it is concluded that total pulpotomy with Biodentine has a promising scope in regenerative approaches in the treatment of carious young permanent teeth. KEY WORDS Biodentine, Coronal Pulpotomy, Permanent Teeth, Total Pulpotomy
BACKGROUND Glass ionomer cement (GIC) is a versatile restorative cement in paediatric dentistry. Due to its less flexural strength, alternative materials have been developed. Cention N is one such material, but since it’s a new material evidence is lacking regarding its physical properties, especially flexural strength for evaluating its clinical outcome. We wanted to compare the flexural strength of glass ionomer cement and Cention N stored in artificial saliva and its variation over different time intervals, i.e., after 24 hours, 1 week and 4 weeks. METHODS A total of 30 specimens were prepared for GIC (Fuji IX) and Cention N and were further categorized according to the duration of storage time of 24 hours, 1 week and 4 weeks (N = 10). A 3 - point bending test using a universal testing machine was used to evaluate the flexural strength. RESULTS GIC Fuji IX showed a mean flexural strength of 35.296 ± 1.61 Mpa at the end of 24 hours, 47.234 ± 4.12 after 1 week and 66.039 ± 11.05 Mpa at the end of 4 weeks. GIC showed a statistically significant increase of flexural strength from 24 hours to one week and a further increase after 4 weeks of storage. The flexural strength of Cention N at 24 hours was 175.985 ± 22.11 Mpa, at the end of one week was 163.486 ± 17.55 MPa, and after 4 weeks was 175.437 ± 27.22 Mpa. Cention N did not show any statistically significant change in flexural strength value from 24 hours to 4 weeks. Cention N showed highly significant difference between flexural strength compared to GIC at all - time intervals. CONCLUSIONS Cention N has a superior flexural strength compared to GIC at all - time intervals. KEY WORDS Cention N, Flexural Strength, Glass Ionomer Cement
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.